Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome
GET TICKETS

Factors of Influence in 2019, Key Indicators and Opportunity within Toyota Motor, UROGEN PHARMA, Macerich, Cosan, Middlesex Water, and Howard Hughes — New Research Emphasizes Economic Growth

Share:

NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Toyota Motor Corporation (NYSE:TM), UROGEN PHARMA (NASDAQ:URGN), Macerich Company (NYSE:MAC), Cosan Limited (NYSE:CZZ), Middlesex Water Company (NASDAQ:MSEX), and Howard Hughes Corporation (NYSE:HHC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TM DOWNLOAD: http://MarketSourceResearch.com/register/?so=TM
URGN DOWNLOAD: http://MarketSourceResearch.com/register/?so=URGN
MAC DOWNLOAD: http://MarketSourceResearch.com/register/?so=MAC
CZZ DOWNLOAD: http://MarketSourceResearch.com/register/?so=CZZ
MSEX DOWNLOAD: http://MarketSourceResearch.com/register/?so=MSEX
HHC DOWNLOAD: http://MarketSourceResearch.com/register/?so=HHC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Toyota Motor Corporation (NYSE:TM), UROGEN PHARMA (NASDAQ:URGN), Macerich Company (NYSE:MAC), Cosan Limited (NYSE:CZZ), Middlesex Water Company (NASDAQ:MSEX), and Howard Hughes Corporation (NYSE:HHC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 13th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TOYOTA MOTOR CORPORATION (TM) REPORT OVERVIEW

Toyota Motor's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Toyota Motor reported revenue of $69,433.73MM vs $67,691.33MM (up 2.57%) and analysts estimated basic earnings per share $1.10 vs $5.68 (down 80.61%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Toyota Motor reported revenue of $264,415.60MM vs $256,653.90MM (up 3.02%) and analysts estimated basic earnings per share $15.16 vs $11.26 (up 34.58%). Analysts expect earnings to be released on May 14th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $3.00. The estimated EPS forecast for the next fiscal year is $15.70 and is expected to report on May 14th, 2019.

To read the full Toyota Motor Corporation (TM) report, download it here: http://MarketSourceResearch.com/register/?so=TM

-----------------------------------------

UROGEN PHARMA (URGN) REPORT OVERVIEW

UROGEN PHARMA's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, UROGEN PHARMA reported revenue of $0.28MM vs $7.81MM (down 96.38%) and analysts estimated basic earnings per share -$1.28 vs -$0.02. For the twelve months ended December 31st, 2017 vs December 31st, 2016, UROGEN PHARMA reported revenue of $8.16MM vs $17.53MM (down 53.46%) and analysts estimated basic earnings per share -$2.14 vs -$1.91. Analysts expect earnings to be released on March 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.74. The estimated EPS forecast for the next fiscal year is -$5.04 and is expected to report on March 21st, 2019.

To read the full UROGEN PHARMA (URGN) report, download it here: http://MarketSourceResearch.com/register/?so=URGN

-----------------------------------------

MACERICH COMPANY (MAC) REPORT OVERVIEW

Macerich's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Macerich reported revenue of $242.20MM vs $242.45MM (down 0.10%) and analysts estimated basic earnings per share $0.52 vs $0.12 (up 333.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Macerich reported revenue of $993.66MM vs $1,041.27MM (down 4.57%) and analysts estimated basic earnings per share $1.02 vs $3.52 (down 71.02%). Analysts expect earnings to be released on May 1st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.82. The estimated EPS forecast for the next fiscal year is $3.79 and is expected to report on February 6th, 2020.

To read the full Macerich Company (MAC) report, download it here: http://MarketSourceResearch.com/register/?so=MAC

-----------------------------------------

COSAN LIMITED (CZZ) REPORT OVERVIEW

Cosan's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Cosan reported revenue of $1,213.72MM vs $1,173.80MM (up 3.40%) and basic earnings per share $0.07 vs $0.30 (down 77.93%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cosan reported revenue of $4,254.03MM vs $3,588.95MM (up 18.53%) and analysts estimated basic earnings per share $0.66 vs $0.30 (up 118.01%). Analysts expect earnings to be released on March 1st, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is $0.81 and is expected to report on March 1st, 2019.

To read the full Cosan Limited (CZZ) report, download it here: http://MarketSourceResearch.com/register/?so=CZZ

-----------------------------------------

MIDDLESEX WATER COMPANY (MSEX) REPORT OVERVIEW

Middlesex Water's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Middlesex Water reported revenue of $38.71MM vs $36.17MM (up 7.02%) and analysts estimated basic earnings per share $0.75 vs $0.47 (up 59.57%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Middlesex Water reported revenue of $130.78MM vs $132.91MM (down 1.60%) and analysts estimated basic earnings per share $1.39 vs $1.39 (unchanged). Analysts expect earnings to be released on March 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.32. The estimated EPS forecast for the next fiscal year is $2.05 and is expected to report on March 8th, 2019.

To read the full Middlesex Water Company (MSEX) report, download it here: http://MarketSourceResearch.com/register/?so=MSEX

-----------------------------------------

HOWARD HUGHES CORPORATION (HHC) REPORT OVERVIEW

Howard Hughes' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Howard Hughes reported revenue of $257.16MM vs $258.74MM (down 0.61%) and analysts estimated basic earnings per share $0.54 vs $0.25 (up 116.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Howard Hughes reported revenue of $1,100.12MM vs $1,035.01MM (up 6.29%) and analysts estimated basic earnings per share $4.07 vs $5.12 (down 20.51%). Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.28.

To read the full Howard Hughes Corporation (HHC) report, download it here: http://MarketSourceResearch.com/register/?so=HHC

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
FRPTInitiates Coverage On60.0
NOMDInitiates Coverage On26.0
SMPLInitiates Coverage On27.0
TWNKInitiates Coverage On16.0
IQVMaintains150.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com